No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Aligos Therapeutics, Inc.'s (NASDAQ:ALGS) Biggest Owners Are Retail Investors Who Got Richer After Stock Soared 17% Last Week
NASDAQ New 52-Week Highs And Lows
Express News | Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aligos Therapeutics to Present at Investor Conferences in December
Express News | Adage Capital Management, L.p. Reports 7.12% Passive Stake in Aligos Therapeutics as of Sept 30 - SEC Filing